Global Biosimilar Monoclonal Antibodies Market Intelligence Report for Comprehensive Information 2019-2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jan-2019   |    Format :PDF   |    Number of Pages : 123
This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report 
    ProMab Biotechnologies
    Allergan plc
    Abbott
    BioXpress Therapeutics
    Bayer
    Bio Farma
    Merck
    Therapeutics
    Biocon
    Boehringer Ingelheim
    Celltrion Inc.
    Coherus BioSciences Inc.
    Zydus-Cadila
    Genor BioPharma
    Intas Pharmaceuticals
    Novartis
    Pfizer
    Reliance Life Sciences

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Infliximab
    Rituximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

The study objectives of this report are:
    To analyze and study the global Biosimilar Monoclonal Antibodies capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Biosimilar Monoclonal Antibodies manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biosimilar Monoclonal Antibodies Manufacturers
Biosimilar Monoclonal Antibodies Distributors/Traders/Wholesalers
Biosimilar Monoclonal Antibodies Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biosimilar Monoclonal Antibodies market, by end-use.
Detailed analysis and profiles of additional market players.

Global Biosimilar Monoclonal Antibodies Market Research Report 2018
1 Biosimilar Monoclonal Antibodies Market Overview
    1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
    1.2 Biosimilar Monoclonal Antibodies Segment by Type (Product Category)
        1.2.1 Global Biosimilar Monoclonal Antibodies Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        1.2.2 Global Biosimilar Monoclonal Antibodies Production Market Share by Type (Product Category) in 2017
        1.2.3 Infliximab
        1.2.3 Rituximab
        1.2.5 Abciximab
        1.2.6 Trastuzumab
        1.2.7 Adalimumab
         Bevacizumab
    1.3 Global Biosimilar Monoclonal Antibodies Segment by Application
        1.3.1 Biosimilar Monoclonal Antibodies Consumption (Sales) Comparison by Application (2013-2025)
        1.3.2 Oncology
        1.3.3 Chronic and Autoimmune Diseases
        1.3.4 Growth Hormone Deficiency
        1.3.5 Infectious Diseases
        1.3.6 Others
    1.4 Global Biosimilar Monoclonal Antibodies Market by Region (2013-2025)
        1.4.1 Global Biosimilar Monoclonal Antibodies Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        1.4.2 North America Status and Prospect (2013-2025)
        1.4.3 Europe Status and Prospect (2013-2025)
        1.4.4 China Status and Prospect (2013-2025)
        1.4.5 Japan Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Status and Prospect (2013-2025)
        1.4.7 India Status and Prospect (2013-2025)
    1.5 Global Market Size (Value) of Biosimilar Monoclonal Antibodies (2013-2025)
        1.5.1 Global Biosimilar Monoclonal Antibodies Revenue Status and Outlook (2013-2025)
        1.5.2 Global Biosimilar Monoclonal Antibodies Capacity, Production Status and Outlook (2013-2025)

2 Global Biosimilar Monoclonal Antibodies Market Competition by Manufacturers
    2.1 Global Biosimilar Monoclonal Antibodies Capacity, Production and Share by Manufacturers (2013-2018)
        2.1.1 Global Biosimilar Monoclonal Antibodies Capacity and Share by Manufacturers (2013-2018)
        2.1.2 Global Biosimilar Monoclonal Antibodies Production and Share by Manufacturers (2013-2018)
    2.2 Global Biosimilar Monoclonal Antibodies Revenue and Share by Manufacturers (2013-2018)
    2.3 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2013-2018)
    2.4 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
        2.5.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
        2.5.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Biosimilar Monoclonal Antibodies Capacity, Production, Revenue (Value) by Region (2013-2018)
    3.1 Global Biosimilar Monoclonal Antibodies Capacity and Market Share by Region (2013-2018)
    3.2 Global Biosimilar Monoclonal Antibodies Production and Market Share by Region (2013-2018)
    3.3 Global Biosimilar Monoclonal Antibodies Revenue (Value) and Market Share by Region (2013-2018)
    3.4 Global Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.5 North America Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.6 Europe Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.7 China Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.8 Japan Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.9 Southeast Asia Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.10 India Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Biosimilar Monoclonal Antibodies Supply (Production), Consumption, Export, Import by Region (2013-2018)
    4.1 Global Biosimilar Monoclonal Antibodies Consumption by Region (2013-2018)
    4.2 North America Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)
    4.3 Europe Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)
    4.4 China Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)
    4.5 Japan Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)
    4.6 Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)
    4.7 India Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import (2013-2018)

5 Global Biosimilar Monoclonal Antibodies Production, Revenue (Value), Price Trend by Type
    5.1 Global Biosimilar Monoclonal Antibodies Production and Market Share by Type (2013-2018)
    5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
    5.3 Global Biosimilar Monoclonal Antibodies Price by Type (2013-2018)
    5.4 Global Biosimilar Monoclonal Antibodies Production Growth by Type (2013-2018)

6 Global Biosimilar Monoclonal Antibodies Market Analysis by Application
    6.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2013-2018)
    6.2 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2013-2018)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Biosimilar Monoclonal Antibodies Manufacturers Profiles/Analysis
    7.1 ProMab Biotechnologies
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 Allergan plc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Allergan plc Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Abbott
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Abbott Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 BioXpress Therapeutics
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Bayer
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Bayer Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        7.5.4 Main Business/Business Overview
    7.6 Bio Farma
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Bio Farma Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 Merck
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Merck Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Therapeutics
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Therapeutics Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 Biocon
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Biocon Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.9.4 Main Business/Business Overview
    7.8 Boehringer Ingelheim
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.10.4 Main Business/Business Overview
    7.11 Celltrion Inc.
    7.12 Coherus BioSciences Inc.
    7.13 Zydus-Cadila
    7.14 Genor BioPharma
    7.15 Intas Pharmaceuticals
    7.16 Novartis
    7.17 Pfizer
    7.18 Reliance Life Sciences

8 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
    8.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Biosimilar Monoclonal Antibodies Market Forecast (2018-2025)
    12.1 Global Biosimilar Monoclonal Antibodies Capacity, Production, Revenue Forecast (2018-2025)
        12.1.1 Global Biosimilar Monoclonal Antibodies Capacity, Production and Growth Rate Forecast (2018-2025)
        12.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
        12.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2018-2025)
    12.2 Global Biosimilar Monoclonal Antibodies Production, Consumption , Import and Export Forecast by Region (2018-2025)
        12.2.1 North America Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.2 Europe Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.3 China Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.4 Japan Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.5 Southeast Asia Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.6 India Biosimilar Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.3 Global Biosimilar Monoclonal Antibodies Production, Revenue and Price Forecast by Type (2018-2025)
    12.4 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer



List of Tables and Figures

    Figure Picture of Biosimilar Monoclonal Antibodies
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Types (Product Category) in 2017
    Figure Product Picture of Infliximab
    Table Major Manufacturers of Infliximab
    Figure Product Picture of Rituximab
    Table Major Manufacturers of Rituximab
    Figure Product Picture of Abciximab
    Table Major Manufacturers of Abciximab
    Figure Product Picture of Trastuzumab
    Table Major Manufacturers of Trastuzumab
    Figure Product Picture of Adalimumab
    Table Major Manufacturers of Adalimumab
    Figure Product Picture of Bevacizumab
    Table Major Manufacturers of Bevacizumab
    Figure Global Biosimilar Monoclonal Antibodies Consumption (K Units) by Applications (2013-2025)
    Figure Oncology Examples
    Table Key Downstream Customer in Oncology
    Figure Chronic and Autoimmune Diseases Examples
    Table Key Downstream Customer in Chronic and Autoimmune Diseases
    Figure Growth Hormone Deficiency Examples
    Table Key Downstream Customer in Growth Hormone Deficiency
    Figure Infectious Diseases Examples
    Table Key Downstream Customer in Infectious Diseases
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Biosimilar Monoclonal Antibodies Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
    Figure North America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Capacity, Production (K Units) Status and Outlook (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Major Players Product Capacity (K Units) (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Capacity (K Units) of Key Manufacturers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Capacity Market Share of Key Manufacturers (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Capacity (K Units) of Key Manufacturers in 2017
    Figure Global Biosimilar Monoclonal Antibodies Capacity (K Units) of Key Manufacturers in 2018
    Figure Global Biosimilar Monoclonal Antibodies Major Players Product Production (K Units) (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) of Key Manufacturers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Production Share by Manufacturers (2013-2018)
    Figure 2017 Biosimilar Monoclonal Antibodies Production Share by Manufacturers
    Figure 2017 Biosimilar Monoclonal Antibodies Production Share by Manufacturers
    Figure Global Biosimilar Monoclonal Antibodies Major Players Product Revenue (Million USD) (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2013-2018)
    Table 2017 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
    Table 2018 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
    Table Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2013-2018)
    Figure Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers in 2017
    Table Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area
    Table Manufacturers Biosimilar Monoclonal Antibodies Product Category
    Figure Biosimilar Monoclonal Antibodies Market Share of Top 3 Manufacturers
    Figure Biosimilar Monoclonal Antibodies Market Share of Top 5 Manufacturers
    Table Global Biosimilar Monoclonal Antibodies Capacity (K Units) by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Capacity Market Share by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Capacity Market Share by Region (2013-2018)
    Figure 2017 Global Biosimilar Monoclonal Antibodies Capacity Market Share by Region
    Table Global Biosimilar Monoclonal Antibodies Production by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Region (2013-2018)
    Figure 2017 Global Biosimilar Monoclonal Antibodies Production Market Share by Region
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2013-2018)
    Table 2017 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region
    Figure Global Biosimilar Monoclonal Antibodies Capacity, Production (K Units) and Growth Rate (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table North America Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Market by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2013-2018)
    Figure 2017 Global Biosimilar Monoclonal Antibodies Consumption (K Units) Market Share by Region
    Table North America Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Production Share by Type (2013-2018)
    Figure Production Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
    Figure 2017 Production Market Share of Biosimilar Monoclonal Antibodies by Type
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
    Figure Production Revenue Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
    Figure 2017 Revenue Market Share of Biosimilar Monoclonal Antibodies by Type
    Table Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Production Growth by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) by Application (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Applications (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2017
    Table Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2013-2018)
    Table ProMab Biotechnologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Allergan plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Allergan plc Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Abbott Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table BioXpress Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bayer Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Bio Farma Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bio Farma Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Merck Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Therapeutics Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Biocon Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Growth Rate (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Market Share (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Revenue Market Share (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
    Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table Major Buyers of Biosimilar Monoclonal Antibodies
    Table Distributors/Traders List
    Figure Global Biosimilar Monoclonal Antibodies Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Price (Million USD) and Trend Forecast (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Region (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share Forecast by Region (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Forecast by Region (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Region (2018-2025)
    Figure North America Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure North America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table North America Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Asia-Pacific Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Europe Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Central & South America Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Central & South America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Central & South America Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure India Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table India Biosimilar Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Type (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Forecast by Application (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Consumption (K Units) Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Source

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...